Durect Corp

NASDAQ:DRRX  
0.91
-0.07 (-6.90%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)206.26M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.1 Million
Adjusted EPS-$0.05
See more estimates
10-Day MA$1.01
50-Day MA$1.18
200-Day MA$1.55
See more pivots

Durect Corp Stock, NASDAQ:DRRX

10260 Bubb Road, Cupertino, California 95014-4166
United States of America
Phone: +1.408.777.1417
Number of Employees: 81

Description

DURECT Corp. focuses in advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.